• Zum Hauptinhalt springen
  • Zum Footer springen

DFG-Forscher...

  • About
  • News
  • Projects
    • Project 1 - Development of a Gene Therapy for Usher Syndrome Type 1B (USH1B)
    • Project 2 - Evaluation of novel gene therapy approaches for USH2A
    • Project 3 - Retina organoids as models for assessing pathomechanisms and effects of novel treatments inn retinal disorders
    • Project 4 - Development of a one-time gene therapy for age-related macular degeneration
    • Project 5 - Development of novel gene therapy strategies for treatment of autosomal dominant retinitis pigmentosa in a pig model
    • Project 6 - Novel targets for gene therapy in diabetic retinopathy (DR)
    • Project 7 - RPE plasticity in the context of neurodegenerative disease: Understanding the limits, pushing the boundaries
    • Project 8 - Novel AI-based biomarkers for retinal gene therapy outcomes by integrating functional neuroimaging and retinal imaging
    • Project 9 - Integrating imaging, clinical and genetic data with machine learning to establish biomarkers for retinal diseases
  • Project leaders
  • Publications
  1. DFG-Forschergruppe 5621
  2. News
  3. OCU-GT International Symposium
News | 16/04/2026

OCU-GT International Symposium

Scientific Experts Gather at Lake Starnberg to Advance Ocular Gene Therapy

This summer, the scenic shores of Lake Starnberg will host some of the world’s leading minds in ophthalmology. From July 13 to 15, 2026, the research unit FOR5621 (OCU-GT) will convene the international symposium "Addressing Unmet Needs in Ocular Gene Therapy" at the historic Evangelische Akademie Tutzing.

As the flagship event of its first funding period, the symposium marks a significant milestone in the research unit's quest to treat previously incurable vision disorders. 

The three-day event will serve as a collaborative bridge between foundational research and clinical application. Highlights of the program include:

Global Expertise: Lectures from renowned external scientists at the forefront of gene therapy.

Project Milestones: In-depth progress reports from the leaders of the nine subprojects within the FOR5621 research unit.

The Next Generation: A dedicated poster session showcasing the work of junior researchers.

We are looking forward to this event and expect a focused environment, that contributes to accelarating the transition from laboratory breakthroughs to tangible patient benefits.

FOR 5621 Research unit

Coordination

Mathildenstr. 8
80336 Munich
+49 89 2180 77337
Swüp6412Svim Sful#vf,iuyziuemi
Editor login
Imprint | Data-Safety | Accessibility